Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate whether armodafinil treatment is more
effective than placebo as adjunctive therapy to antipsychotic medication in alleviating the
negative symptoms of schizophrenia